Glucotrack (GCTK) Capital Expenditures Growth (5y) (2016 - 2025)
Glucotrack (GCTK) Capital Expenditures Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Glucotrack | 1.68 Mn | 553,542.53 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.36% |
| Sep 30, 2025 | 16.67% |
| Mar 31, 2025 | -9.71% |
| Sep 30, 2024 | 21.16% |
| Jun 30, 2024 | 27.69% |
| Mar 31, 2024 | 56.04% |
| Sep 30, 2020 | -16.38% |
| Mar 31, 2020 | 4.38% |
| Sep 30, 2019 | 28.80% |
| Jun 30, 2019 | -38.15% |
| Mar 31, 2019 | -6.35% |
| Dec 31, 2018 | -31.61% |
| Sep 30, 2018 | -38.30% |
| Jun 30, 2018 | -50.55% |
| Mar 31, 2018 | 3.44% |
| Sep 30, 2017 | 33.46% |
| Jun 30, 2017 | 12.82% |
| Mar 31, 2017 | -2.44% |
| Sep 30, 2016 | 38.63% |
| Jun 30, 2016 | -12.06% |